NMPA-2021-0024-V324

Type II variation for application NMPA-2021-0024. Type II variation: New Dosage Strength for Semaglutidex — major revision

Variation Number
NMPA-2021-0024-V324
Type
Type II
Application
NMPA-2021-0024
Change
CHG-2021-0024
Status
Pending
Fee
€52,236
Submitted
2023-12-14
Approved
—
Description

Type II variation: New Dosage Strength for Semaglutidex — major revision